[99mTc]MIP-1405

N/A

Report date: 2025/11/20 16:02:30

Base Information

Drug Name[99mTc]MIP-1405

Drug Alias Name[99mTc]MIP-1405[99mTc]MIP-1340 (former code)99mTc-MIP-1405

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Technetium > 99mTc +[5]

Mechanisms of ActionDiagnostic imaging enhancersAntigens inhibitors

TargetsAntigens

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesProgenics Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecular Insight Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A